null
SMILES: COc1cc(OCc2cccc(c2C)-c2ccccc2)cc(OCc2cccc(c2)C#N)c1CN[C@@H]([C@H](C)O)C(O)=O
InChI Key: InChIKey=MWGTVYDWJRCRQT-WYOOIXGGSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM363213![]() ((2S,3S)-2-((2-((3-cyanobenzyl)oxy)-6-methoxy-4-((2...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US9850225 (2017) BindingDB Entry DOI: 10.7270/Q2N018TZ | |||||||||||
More data for this Ligand-Target Pair |